Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-19.03 Insider Own3.13% Shs Outstand0.62M Perf Week10.75%
Market Cap1.82M Forward P/E- EPS next Y-5.25 Insider Trans3.46% Shs Float0.60M Perf Month-12.91%
Income-15.37M PEG- EPS next Q-2.05 Inst Own21.17% Short Float / Ratio0.80% / 0.31 Perf Quarter-32.06%
Sales5.50M P/S0.33 EPS this Y70.16% Inst Trans- Short Interest0.00M Perf Half Y-38.34%
Book/sh13.99 P/B0.21 EPS next Y43.27% ROA-52.78% Target Price11.00 Perf Year-78.29%
Cash/sh25.32 P/C0.12 EPS next 5Y14.96% ROE-75.31% 52W Range2.60 - 18.94 Perf YTD-72.93%
Dividend- P/FCF- EPS past 5Y38.49% ROI-96.78% 52W High-84.50% Beta0.73
Dividend %- Quick Ratio4.47 Sales past 5Y106.94% Gross Margin18.84% 52W Low12.88% ATR0.23
Employees30 Current Ratio5.15 Sales Q/Q-14.96% Oper. Margin-298.16% RSI (14)44.72 Volatility8.01% 7.12%
OptionableNo Debt/Eq0.08 EPS Q/Q59.57% Profit Margin-279.75% Rel Volume0.00 Prev Close2.93
ShortableYes LT Debt/Eq0.02 EarningsNov 09 AMC Payout- Avg Volume15.28K Price2.93
Recom1.00 SMA20-2.84% SMA50-7.67% SMA200-39.52% Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-17-20Reiterated H.C. Wainwright Buy $14 → $12
May-12-17Downgrade Piper Jaffray Overweight → Neutral
Jun-09-15Initiated Piper Jaffray Overweight $10
Jun-09-15Initiated Credit Suisse Outperform $14
Nov-11-23 12:02PM
Nov-10-23 10:26AM
Nov-09-23 04:47PM
Oct-26-23 08:02AM
06:51AM Loading…
Oct-25-23 06:51AM
Oct-03-23 08:02AM
Sep-05-23 08:02AM
Sep-01-23 09:43AM
Aug-11-23 06:58AM
Aug-10-23 06:05PM
Aug-09-23 06:05PM
Aug-08-23 06:05PM
10:19AM Loading…
Jul-27-23 10:19AM
Jul-21-23 10:04AM
Jul-20-23 08:02AM
Jul-17-23 08:02AM
Jun-14-23 10:04AM
May-12-23 05:41AM
May-11-23 04:05PM
May-08-23 08:01AM
Apr-28-23 08:02AM
Apr-09-23 07:33PM
Mar-30-23 04:38PM
Mar-23-23 06:54AM
Mar-22-23 10:22AM
07:00PM Loading…
Mar-02-23 07:00PM
Mar-01-23 01:54PM
Jan-19-23 09:07AM
Jan-18-23 08:00AM
Dec-28-22 08:10AM
Dec-08-22 08:00AM
Nov-30-22 04:30PM
Nov-13-22 07:55AM
Nov-10-22 07:05PM
Oct-27-22 08:00AM
Sep-29-22 01:38PM
Aug-31-22 08:00AM
Aug-16-22 05:00PM
Aug-12-22 07:10PM
Aug-11-22 04:05PM
Jul-28-22 08:00AM
Jun-01-22 05:52PM
May-12-22 04:05PM
May-05-22 08:00AM
Mar-30-22 04:05PM
Mar-23-22 08:00AM
Mar-22-22 08:45AM
Mar-16-22 09:19PM
Feb-03-22 09:45AM
Feb-02-22 04:05PM
Dec-20-21 05:33PM
Nov-22-21 08:00AM
Nov-15-21 04:05PM
Nov-08-21 08:00AM
Sep-07-21 04:10PM
Aug-16-21 04:05PM
Aug-09-21 08:00AM
Jul-20-21 07:00AM
Jun-17-21 05:40AM
May-17-21 04:05PM
May-10-21 08:30AM
Apr-20-21 08:00AM
Apr-19-21 08:00AM
Apr-14-21 05:37AM
Mar-31-21 06:19AM
Mar-30-21 04:05PM
Mar-29-21 10:05AM
Mar-23-21 08:00AM
Mar-04-21 08:00AM
Mar-02-21 08:00AM
Feb-24-21 01:04PM
Feb-19-21 05:25AM
Feb-02-21 08:00AM
Jan-27-21 06:58PM
Jan-25-21 09:00AM
Dec-22-20 01:00PM
Dec-18-20 09:00AM
Nov-24-20 08:00AM
Nov-12-20 02:30PM
Nov-11-20 10:17AM
Nov-10-20 08:00AM
Nov-06-20 08:00AM
Sep-17-20 08:00AM
Sep-09-20 08:00AM
Sep-01-20 08:00AM
Aug-18-20 01:53AM
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schaefer Thomas J.Chief Financial OfficerAug 04Buy3.676492,382719Aug 07 07:55 PM
Jacot Stanley JrChief Executive OfficerMay 30Buy4.315,00021,5505,000May 30 06:24 PM
Schaefer Thomas J.Chief Financial OfficerFeb 01Buy0.237001612,800Feb 02 07:07 PM